prostate-cancer

Documents about prostate-cancer

• Outdoor air pollution and prostate cancer risk in the NIH-AARP diet and health study.#174754NCBI PubMed Central
• Racial and ethnic differences in valuation of life expectancy in prostate cancer treatment decision making.#219108NCBI PubMed Central
• CAVPENET Peptide Inhibits Prostate Cancer Cells Proliferation and Migration through PP1γ-Dependent Inhibition of AKT Signaling#254175HAL (France)
• Impact of AI-Generated ADC Maps on Computer-Aided Diagnosis of Prostate Cancer: A Feasibility Study.#258204NCBI PubMed Central
• The unmet needs of gay and bisexual men following prostate cancer treatment : an integrative literature review#270437The Learning Edge
• HSP27 functional switch drives castration-resistant prostate cancer via mTOR pathway activation, highlighting promising combination therapies#311913HAL (France)
• Magnetic Resonance Imaging-based Prostate Cancer Diagnosis Using Principal Component Analysis and Machine Learning Algorithms.#354738NCBI PubMed Central
• Implementing intervention mapping to tailor the evidence-based PREDIMED intervention for medically underserved prostate cancer patients.#375545NCBI PubMed Central
• Machine Learning Classification of Prostate Cancer Genomic Sequences Using K-Mer and Sequence-Derived Features.#378432NCBI PubMed Central
• Perceived cognitive impairment and occupational functioning in prostate cancer survivors: an exploratory cross-sectional analysis.#380625NCBI PubMed Central
• Circadian Disruption, Sleep Loss, and Prostate Cancer Risk: A Systematic Review of Epidemiologic Studies#384020CiNii
• Serum phytoestrogens and prostate cancer risk in a nested case-control study among Japanese men#384126CiNii
• Decoding 3D chromatin architecture reveals distinct enhancer classes underlying hierarchical gene regulation in prostate cancer.#396075NCBI PubMed Central
• Hypusination of the translation factor eIF5A regulates mitochondrial tRNA processing to promote prostate cancer aggressiveness#405782HAL (France)
• A Phase 1 Study To Evaluate Escalating Doses Of A Vaccine-Based Immunotherapy Regimen For Prostate Cancer (PrCa VBIR)#414359ClinicalTrials.gov
• Thinking, Feeling, Choosing: How Affect Is Reflected in Prostate Cancer Treatment Decision Making-A Qualitative Study.#442847NCBI PubMed Central
• Preoperative Magnetic Resonance Imaging Findings of the Transition Zone Predict Incidental Prostate Cancer in HoLEP.#636298NCBI PubMed Central
• Systematic adaptation of ProSleep for men initiating androgen-deprivation therapy for prostate cancer: development of ProSleep-Pro#637122PsyArXiv
• A Prospective Study of Intake of Fish and Marine Fatty Acids and Prostate Cancer#643911Harvard DASH
• A seven-variable clinical prediction model for bone metastasis at initial diagnosis of prostate cancer.#685630NCBI PubMed Central
• Incidence of Second Primary Malignancies in Castration-Resistant Prostate Cancer: An Observational Retrospective Cohort Study in the US#828640ClinicalTrials.gov
• NMR quantification of lactate production and efflux and glutamate fractional enrichment in living human prostate biopsies cultured with [1,6‐13C2]glucose#620168eScholarship
• Comprehensive assessment of estrogen receptor beta antibodies in cancer cell line models and tissue reveals critical limitations in reagent specificity#379776Apollo
• PSMA and TARP Peptide Vaccine With Poly IC-LC Adjuvant in HLA-A2 (+) Patients With Elevated PSA After Initial Definitive Treatment#435751ClinicalTrials.gov
• 68Ga-RM26-RGD PET/CT Imaging in the GRPR and αvβ3 Positive Tumor Patients#800619ClinicalTrials.gov
• Dynamics of Androgen Receptor Genomics and Transcriptomics After Neoadjuvant Androgen Ablation#840426ClinicalTrials.gov
• Integrating network toxicology, machine learning, and single-cell sequencing to reveal the FASN-mediated role of phenolic endocrine disruptors in water in promoting prostate cancer#251485PLOS
• Physician-Initiated Stop-Smoking Program for Patients Receiving Treatment for Early-Stage Cancer#834113ClinicalTrials.gov
• Expanded Access Protocol for the Use of SL-28 in the Treatment of Advanced Solid Tumors#201781ClinicalTrials.gov
• Cold spot mapping inferred from MRI at time of failure predicts biopsy-proven local failure after permanent seed brachytherapy in prostate cancer patients: Implications for focal salvage brachytherapy#675902eScholarship
• PANDA-PLUS: Improved dataset of prostate whole slide images from PANDA Challenge with pixel-level expert annotations#390812BYU ScholarsArchive
• Rapid Modulation of Circulating Adipokines and Inflammatory Cytokines in Localized Prostate Cancer Following Short-Term Leuprolide Therapy.#9139NCBI PubMed Central
• Combined radiomics, PI-RADS, and clinical model improve significant prostate cancer prediction and guide biopsy decision.#135746NCBI PubMed Central
• The Experiences and Perspective of Partners of Men With Prostate Cancer in Ireland: A Qualitative Descriptive Study.#156769NCBI PubMed Central
• Variation of the relative biological effectiveness with fractionation in proton therapy: analysis of prostate cancer response#176467arXiv Biology
• Variation of the relative biological effectiveness with fractionation in proton therapy: analysis of prostate cancer response#176951arXiv (OAI)
• Variation of the relative biological effectiveness with fractionation in proton therapy: analysis of prostate cancer response#177205arXiv (OAI Expanded)
• Variation of the relative biological effectiveness with fractionation in proton therapy: analysis of prostate cancer response#177685arXiv
• Tissue-specific transfer learning improves functional variant and therapeutic target discoveries in breast and prostate cancer.#185916NCBI PubMed Central
• REST mediates androgen receptor actions on gene repression and predicts early recurrence of prostate cancer.#275050Lund University Publications
• Electrolyte trajectory-based subphenotypes and their association with hospital length of stay in prostate cancer patients.#280953NCBI PubMed Central
• Mechanistic Language Modeling and Oxygenated 3D Screening Reveal Berberine and Enzalutamide Synergy in Resistant Prostate Cancer#291363Europe PMC
• Pioglitazone and Insulin Resistance in ADT#337095ClinicalTrials.gov
• Integrative Multi-Omics Analysis Reveals the Tumor-Suppressive and Immunoregulatory Roles of SEMA5B in Prostate Cancer.#342458NCBI PubMed Central
• A modular patient-derived organoid–xenograft platform reveals molecular and clinical trajectories of prostate cancer progression#357105Europe PMC
• Development of a prostate cancer survivorship care toolkit for Black men with clinical and contextual tailoring.#402439NCBI PubMed Central
• Developing an OMOP-Standardized Prostate Cancer Database and Improving Data Quality Using NLP and PSA-Based Algorithms#417385bioRxiv / medRxiv
• CAUSAL DISCOVERY WITH MIXED DATA VIA MODEL-BASED CONDITIONAL INDEPENDENCE TESTING#424435DigitalCommons@Kennesaw State University
• Study of Trovax® Plus Docetaxel Versus Docetaxel Alone in Patients With Progressive Hormone Refractory Prostate Cancer#426640ClinicalTrials.gov
• Leveraging MRI to reduce overtreatment in low‑grade prostate cancer: a retrospective single‑centre cohort study.#433999NCBI PubMed Central